Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie L Todd

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Annals of the American Thoracic Society|September 23, 2015
Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease ExacerbationLiza Genao, Michael T Durheim, Xiaojuan Mi, et al.
JHLT Open|February 2, 2026
Abnormal spirometry 1 year after lung transplantation may identify patients at risk for chronic lung allograft dysfunction in a multicenter cohortAlexander R Graham, Maria V Grau-Sepulveda, Jamie L Todd, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 11, 2021
Immunity to varicella, measles, and mumps in patients evaluated for lung transplantationHaley P Hostetler, Megan L Neely, Elizabeth Lydon, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 24, 2018
Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunctionJamie L Todd, Megan L Neely, C A Finlen Copeland, et al.
Chest|September 12, 2018
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary FibrosisScott M Palmer, Laurie Snyder, Jamie L Todd, et al.
American Journal of Respiratory and Critical Care Medicine|December 12, 2013
Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunctionJamie L Todd, Rahil Jain, Elizabeth N Pavlisko, et al.
Chest|February 28, 2025
Changes in Lung Function and Mortality Risk in Patients With Idiopathic Pulmonary FibrosisJustin M Oldham, Megan L Neely, Daniel M Wojdyla, et al.
Lung|August 27, 2025
Changes in Lung Function and Patient-Reported Outcomes in Patients with Idiopathic Pulmonary FibrosisJamie L Todd, Megan L Neely, Anne S Hellkamp, et al.
JCI Insight|March 22, 2023
JAK-STAT activation contributes to cytotoxic T cell-mediated basal cell death in human chronic lung allograft dysfunctionAaditya Khatri, Jamie L Todd, Fran L Kelly, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 31, 2019
Amphiregulin contributes to airway remodeling in chronic allograft dysfunction after lung transplantationJamie L Todd, Fran L Kelly, Andrew Nagler, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Annals of the American Thoracic Society|September 23, 2015
Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease ExacerbationLiza Genao, Michael T Durheim, Xiaojuan Mi, et al.
JHLT Open|February 2, 2026
Abnormal spirometry 1 year after lung transplantation may identify patients at risk for chronic lung allograft dysfunction in a multicenter cohortAlexander R Graham, Maria V Grau-Sepulveda, Jamie L Todd, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 11, 2021
Immunity to varicella, measles, and mumps in patients evaluated for lung transplantationHaley P Hostetler, Megan L Neely, Elizabeth Lydon, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 24, 2018
Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunctionJamie L Todd, Megan L Neely, C A Finlen Copeland, et al.
Chest|September 12, 2018
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary FibrosisScott M Palmer, Laurie Snyder, Jamie L Todd, et al.
American Journal of Respiratory and Critical Care Medicine|December 12, 2013
Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunctionJamie L Todd, Rahil Jain, Elizabeth N Pavlisko, et al.
Chest|February 28, 2025
Changes in Lung Function and Mortality Risk in Patients With Idiopathic Pulmonary FibrosisJustin M Oldham, Megan L Neely, Daniel M Wojdyla, et al.
Lung|August 27, 2025
Changes in Lung Function and Patient-Reported Outcomes in Patients with Idiopathic Pulmonary FibrosisJamie L Todd, Megan L Neely, Anne S Hellkamp, et al.
JCI Insight|March 22, 2023
JAK-STAT activation contributes to cytotoxic T cell-mediated basal cell death in human chronic lung allograft dysfunctionAaditya Khatri, Jamie L Todd, Fran L Kelly, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 31, 2019
Amphiregulin contributes to airway remodeling in chronic allograft dysfunction after lung transplantationJamie L Todd, Fran L Kelly, Andrew Nagler, et al.
Pageof 8